Table of Content

1 Psoriasis Drugs Market Introduction and Overview
1.1 Psoriasis Drugs Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Psoriasis Drugs Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Psoriasis Drugs Revenue and Market Share by Type
3 Global Psoriasis Drugs Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Psoriasis Drugs Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Psoriasis Drugs Market Size (2019-2024)
4.2 Psoriasis Drugs Growth Trends Analysis by Regions
4.2.1 Psoriasis Drugs Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Psoriasis Drugs Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Psoriasis Drugs Market Size (2019-2024)
4.2.4 Europe Psoriasis Drugs Market Size (2019-2024)
4.2.5 Asia-Pacific Psoriasis Drugs Market Size (2019-2024)
4.2.6 Latin America Psoriasis Drugs Market Size (2019-2024)
4.2.7 Middle East & Africa Psoriasis Drugs Market Size (2019-2024)
5 North America
5.1 North America Psoriasis Drugs Revenue by Countries
5.1.1 North America Psoriasis Drugs Revenue by Countries (2019-2024)
5.2 North America Psoriasis Drugs Revenue by Types
5.3 North America Psoriasis Drugs Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Psoriasis Drugs Revenue by Countries
6.1.1 Asia Pacific Psoriasis Drugs Revenue by Countries (2019-2024)
6.2 Asia Pacific Psoriasis Drugs Revenue by Types
6.3 Asia Pacific Psoriasis Drugs Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Psoriasis Drugs Revenue by Countries
7.1.1 Europe Psoriasis Drugs Revenue by Countries (2019-2024)
7.2 Europe Psoriasis Drugs Revenue by Types
7.3 Europe Psoriasis Drugs Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Psoriasis Drugs Revenue by Countries
8.1.1 Latin America Psoriasis Drugs Revenue by Countries (2019-2024)
8.2 Latin America Psoriasis Drugs Revenue by Types
8.3 Latin America Psoriasis Drugs Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Psoriasis Drugs Revenue by Countries
9.1.1 Middle East & Africa Psoriasis Drugs Revenue by Countries (2019-2024)
9.2 Middle East & Africa Psoriasis Drugs Revenue by Types
9.3 Middle East & Africa Psoriasis Drugs Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Psoriasis Drugs Market Competition, by Players
10.1 Global Psoriasis Drugs Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Psoriasis Drugs Players Market Share in 2023
10.2.2 Top 6 Psoriasis Drugs Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Psoriasis Drugs Players Head Office, Business Provided
10.4 Psoriasis Drugs Mergers & Acquisitions
10.5 Psoriasis Drugs New Entrants and Expansion Plans
11 Players Profiles11.1 AbbVie
11.1.1 AbbVie Company Profile
11.1.2 Psoriasis Drugs Product Overview
11.1.3 AbbVie Psoriasis Drugs Market Performance (2019-2024)
11.1.4 AbbVie Business Overview
11.1.5 Recent Developments and Plans
11.2 Amgen
11.2.1 Amgen Company Profile
11.2.2 Psoriasis Drugs Product Overview
11.2.3 Amgen Psoriasis Drugs Market Performance (2019-2024)
11.2.4 Amgen Business Overview
11.2.5 Recent Developments and Plans
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Profile
11.3.2 Psoriasis Drugs Product Overview
11.3.3 Johnson & Johnson Psoriasis Drugs Market Performance (2019-2024)
11.3.4 Johnson & Johnson Business Overview
11.3.5 Recent Developments and Plans
11.4 Novartis
11.4.1 Novartis Company Profile
11.4.2 Psoriasis Drugs Product Overview
11.4.3 Novartis Psoriasis Drugs Market Performance (2019-2024)
11.4.4 Novartis Business Overview
11.4.5 Recent Developments and Plans
11.5 Eli Lilly & Company
11.5.1 Eli Lilly & Company Company Profile
11.5.2 Psoriasis Drugs Product Overview
11.5.3 Eli Lilly & Company Psoriasis Drugs Market Performance (2019-2024)
11.5.4 Eli Lilly & Company Business Overview
11.5.5 Recent Developments and Plans
11.6 AstraZeneca
11.6.1 AstraZeneca Company Profile
11.6.2 Psoriasis Drugs Product Overview
11.6.3 AstraZeneca Psoriasis Drugs Market Performance (2019-2024)
11.6.4 AstraZeneca Business Overview
11.6.5 Recent Developments and Plans
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Profile
11.7.2 Psoriasis Drugs Product Overview
11.7.3 Celgene Corporation Psoriasis Drugs Market Performance (2019-2024)
11.7.4 Celgene Corporation Business Overview
11.7.5 Recent Developments and Plans
11.8 UCB
11.8.1 UCB Company Profile
11.8.2 Psoriasis Drugs Product Overview
11.8.3 UCB Psoriasis Drugs Market Performance (2019-2024)
11.8.4 UCB Business Overview
11.8.5 Recent Developments and Plans
11.9 Merck
11.9.1 Merck Company Profile
11.9.2 Psoriasis Drugs Product Overview
11.9.3 Merck Psoriasis Drugs Market Performance (2019-2024)
11.9.4 Merck Business Overview
11.9.5 Recent Developments and Plans
12 Global Psoriasis Drugs Forecast Market Analysis by Type
12.1 Global Psoriasis Drugs Revenue Market Forecast by Type (2024-2030)
13 Global Psoriasis Drugs Forecast Market Analysis by Application
13.1 Psoriasis Drugs Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Psoriasis Drugs Forecast Market Size (2024-2030)
14.2 Psoriasis Drugs Growth Trends Forecast Analysis by Regions
14.2.1 Psoriasis Drugs Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Psoriasis Drugs Forecast Market Size (2024-2030)
14.2.3 Europe Psoriasis Drugs Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Psoriasis Drugs Forecast Market Size (2024-2030)
14.2.5 Latin America Psoriasis Drugs Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Psoriasis Drugs Forecast Market Size (2024-2030)
15 Psoriasis Drugs Industry Dynamic Analysis
15.1 Psoriasis Drugs Market Trends Analysis
15.2 Psoriasis Drugs Market Drivers Analysis
15.3 Psoriasis Drugs Market Challenges Analysis
15.4 Psoriasis Drugs Market Restraints Analysis